Factors influencing family physicians’ willingness to prescribe opioid agonist therapy using virtual modalities: a qualitative analysis
Sarah Muñoz-Violant, Sarah Spencer, Ellie Gooderham, Shawna Narayan, Bohdan Nosyk, Rita K. McCracken, Lindsay Hedden

TL;DR
This study explores what influences family doctors to prescribe opioid treatment through virtual care, identifying patient, provider, and system factors.
Contribution
The study identifies specific factors influencing family physicians' willingness to prescribe opioid agonist therapy virtually in primary care.
Findings
Patient characteristics and provider-patient relationships influence virtual OAT prescribing decisions.
Interdisciplinary team support and centralized patient data systems facilitate virtual OAT prescribing.
Policy frameworks are needed to support equitable virtual care for opioid use disorder.
Abstract
Although opioid agonist therapy (OAT) is the first-line treatment for Opioid Use Disorder (OUD), access, initiation, and retention rates remain low. An avenue to improve these rates is to enhance OAT delivery in primary care settings. As Canada continues to support hybrid models combining in-person and virtual care, evaluating the role of virtual care in supporting OAT prescribing and OUD management is necessary. This qualitative study explores the factors enabling and hindering family physicians’ willingness to prescribe OAT virtually. Utilizing maximum variation sampling, we conducted semi-structured interviews with 12 family physicians providing care to people with OUD in British Columbia, Canada. We audio-recorded, transcribed verbatim, coded, and thematically analyzed interview data using a hybrid inductive–deductive approach. In this focused analysis, we identified themes across…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · HIV, Drug Use, Sexual Risk
